Further characterization of the epidermal growth factor receptor ligand 11C-PD153035

Chinese Medical Journal

Volumn 120, Issue 11, 2007, Pages 960-964

  Wang, Hui ^a   Yu, Jin Ming ^b   Yang, Guo Ren ^b   Song, Xian Rang ^b   Sun, Xiao Rong ^b   Zhao, Shu Qiang ^b   Wang, Xing Wu ^b   Zhao, Wei ^b  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

4 N (3 bromoanilino) 6,7 dimethoxyquinazoline; Epidermal growth factor receptor; Positron emission tomography; Tyrosine kinase

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; CARBON 11; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER; CARCINOMA CELL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

EID: 34250205633     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200706010-00004     Document Type: Article

References (18)

1. Bazley LA, Gullick WJ. The epidermal growth factor receptor family. Endocr Relat Cancer 2005; 12: 17-27.
2. Vallbohmer D, Lenz HJ. Epidermal growth factor receptor as a target for chemotherapy. Clin Colorectal Cancer 2005; 5: 19-27.
3. Krause M, Zips D, Thames HD, Kummermehr J, Baumann M. Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy. Radiother Oncol 2006; 80: 112-122.
4. Jones HE, Gee JM, Taylor KM, Barrow D, Williams HD, Rubini M, et al. Development of strategies for the use of anti-growth factor treatments. Endocr Relat Cancer 2005; 12: 173-182.
5. Bianco R, Melisi D, Ciardiello F, Tortora G. Key cancer cell signal transduction pathways as therapeutic targets. Eur J Cancer 2006; 42: 290-294.
6. Chung TD, Broaddus WC. Molecular targeting in radiotherapy: epidermal growth factor receptor. Mol Interv 2005; 5: 15-19.
7. Lucignani G, Jereczek-Fossa BA, Orecchia R. The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control. Eur J Nucl Med Mol Imaging 2004; 31: 1059-1063.
8. Van de Wiele C, Lahorte C, Oyen W, Boerman O;Goethals I, Slegers G, et al. Nuclear medicine imaging to predict response to radiotherapy: a review. Int J Radiat Oncol Biol Phys 2003; 55:5-15.
9. Bos M, Mendelsohn J, Kim YM, Albanell J, Fry DW, Baselga J. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res 1997; 3: 2099-2106.
10. Kunkel MW, Hook KE, Howard CT, Przybranowski S, Roberts BJ, Elliott WL, et al. Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice. Invest New Drugs 1996; 13: 295-302.
11. 11C-labeled PD153035 in rats without and with neuroblastoma implants. Life Sci 1999; 65: 165-174.
12. 11C] PD153035, a selective EGF receptor tyrosine kinase inhibitor. J Labelled Cpd 1998; 41: 623-629
13. Atkins D, Reiffen KA, Tegtmeier CL, Winther H, Bonato MS, Storkel S. Immunohistochemical detection EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem 2004; 52: 893-901.
14. Van Den Bossche B, Van de Wiele C. Receptor imaging in oncology by means of nuclear medicine. current status. J Clin Oncol 2004; 22: 3593-3607.
15. Shaul M, Abourbeh G, Jacobson O, Rozen Y, Laky D, Levitzki A, et al. Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer. Bioorg Med Chem 2004; 12: 3421-3429.
16. Bonasera TA, Ortu G, Rozen Y, Krais R, Freedman NMT, Chisin R, et al. Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase. Nucl Med Biol 2001; 28: 359-374.
17. Mishani E, Abourbeh G, Jacobson O, Dissoki S, Ben Daniel R, Rozen Y, et al. High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumors. J Med Chem 2005; 48: 5337-5348.
18. Ren GP, Wang TY, Pan QL, Pao W, Huai J. Epidermal growth factor receptor mutations detected in tumors from Chinese "never smokers" with lung adenocarcinoma. Chin Med J 2005; 118: 769-771.